May 8, 2026

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech with 59.82% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing the attention of investors with its promising potential in the biotechnology sector. As a clinical-stage biopharmaceutical company, Trevi Therapeutics..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Potential 37% Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector specializing in the development of pain management medications, is currently capturing the attention of..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring a 210% Potential Upside Amidst Biotech Innovations

For investors seeking opportunities in the biotechnology sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) presents an intriguing proposition. With its focus on healthy aging products and a..

Replimune Group, Inc. (REPL) Stock Analysis: Navigating the Biotech Landscape with a 4.79% Potential Upside

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative oncolytic immunotherapy product candidates. As the company..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Navigating Biotechnology Prospects with a 16.75% Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a notable player in the healthcare sector, specifically within the biotechnology industry. Headquartered in San Diego, California, Maravai..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A High-Risk Bet with 153% Upside Potential

Investors with a penchant for high-risk, high-reward opportunities may find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) an intriguing prospect. The biopharmaceutical company, with a market capitalization of..

iRadimed Corporation (IRMD) Stock Analysis: Unpacking a 36.81% Potential Upside with Strong Buy Ratings

Investors looking for compelling opportunities in the healthcare sector should turn their attention to iRadimed Corporation (NASDAQ: IRMD), a leading developer and manufacturer of MRI-compatible medical..

GH Research PLC (GHRS) Stock Analysis: Biotech Innovator with 86.82% Potential Upside

GH Research PLC (NASDAQ: GHRS), a promising player in the biopharmaceutical sector, is garnering significant investor attention due to its innovative approach to treating mental health..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a Potential 53% Upside with Strong Buy Ratings

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a compelling investment opportunity in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Unpacking Growth Potential Amidst Analyst Optimism

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a beacon in the biotechnology sector, is drawing significant attention from investors due to its ambitious pipeline and promising market positioning...

Upstream Bio, Inc. (UPB) Stock Analysis: A Promising 384.94% Potential Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB) is gaining attention in the investment community with its remarkable potential upside of 384.94%, according to recent analyst ratings. As a..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Unveiling a Potential 124% Upside for Investors

Vir Biotechnology, Inc. (VIR) stands at a pivotal moment in its growth trajectory, presenting a remarkable investment opportunity for those interested in the healthcare sector, particularly..

CeriBell, Inc. (CBLL) Stock Analysis: A Promising 35% Upside in the Medical Devices Sector

CeriBell, Inc. (NASDAQ: CBLL), a rising star in the healthcare sector, is capturing the attention of investors with its innovative medical device solutions and a substantial..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Revealing a Potential 147.67% Upside

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering biotechnology firm headquartered in Cambridge, UK, is drawing significant attention from the investment community. Operating within the healthcare sector,..

Evolus, Inc. (EOLS): Analyzing a 129% Potential Upside with a Strong Analyst Consensus

Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, is capturing investor interest with a compelling narrative of growth potential. Specializing in the performance..

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 60% Potential Upside in the Biotech Sector

Immunome, Inc. (NASDAQ: IMNM) stands out in the biotechnology sector with its bold strides in oncology therapeutics, particularly in antibody-drug conjugates. Despite a 0.05% dip in..

Delcath Systems, Inc. (DCTH) Stock Analysis: Aiming for an 89.80% Upside in the Medical Device Sector

Delcath Systems, Inc. (NASDAQ: DCTH) is catching the eye of investors with its significant potential upside of 89.80%, as reflected in recent analyst ratings. With a..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 67.87% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector with promising growth potential, despite the challenges highlighted by its recent financial performance. As a..

Talkspace, Inc. (TALK) Stock Analysis: Exploring the 18.73% Potential Upside for Investors

Talkspace, Inc. (TALK), a leader in virtual behavioral healthcare, is gaining attention from investors as it positions itself within the rapidly growing telehealth sector. With a..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Navigating a 32% Potential Upside in the Rare Disease Market

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is steadily capturing the attention of investors with its focused approach in the healthcare sector, specifically targeting the niche market of..

Search

Funds

May 8, 2026

Search

Funds

May 8, 2026

FTSE 100

Funds